Filter Results:
(4,451)
Show Results For
- All HBS Web
(4,451)
- People (16)
- News (1,473)
- Research (2,162)
- Events (3)
- Multimedia (130)
- Faculty Publications (1,512)
Show Results For
- All HBS Web
(4,451)
- People (16)
- News (1,473)
- Research (2,162)
- Events (3)
- Multimedia (130)
- Faculty Publications (1,512)
- 07 Aug 2019
- News
“The Star of the North”
companies. They also boast a rising labor force that’s among the strongest in the country, while the workforces of other states are dwindling. Health care in the area is... View Details
Keywords: Maureen Harmon
- September 2022
- Article
Cost of Cardiac Stereotactic Body Radioablation Therapy versus Catheter Ablation for Treatment of Ventricular Tachycardia
By: Chen Wei, Michelle Boeck, Pierre C. Qian, Todd Vivenzio, Zoe Elizee, Jeremy S. Bredfeldt, Robert S. Kaplan, Usha Tedrow, Raymond Mak and Paul C. Zei
Cardiac SBRT is a novel way of treating refractory ventricular tachycardia (VT) that may be less costly than catheter ablation, owing to its noninvasive, outpatient nature. We applied time-driven activity-based costing to both procedures. The direct and total... View Details
Wei, Chen, Michelle Boeck, Pierre C. Qian, Todd Vivenzio, Zoe Elizee, Jeremy S. Bredfeldt, Robert S. Kaplan, Usha Tedrow, Raymond Mak, and Paul C. Zei. "Cost of Cardiac Stereotactic Body Radioablation Therapy versus Catheter Ablation for Treatment of Ventricular Tachycardia." Pacing and Clinical Electrophysiology 45, no. 9 (September 2022): 1005–1179.
- 01 Mar 2008
- News
Class of 2007 Fellowship Awarded
development. Kim focused on developing a sustainable model for delivering health care to rural India. “If you create a profitable solution, it can be scalable,” he explains. Upon earning his MBA, Kim is... View Details
- 15 Apr 2012
- News
Why Medical Bills Are a Mystery
- March 2008
- Case
The Multiple Sclerosis Center of Atlanta
By: Regina E. Herzlinger and Alfred Martin
The Multiple Sclerosis Center of Atlanta wishes to expand beyond Georgia. The factors influencing this decision are discussed, including drug treatments currently available, and the impact of future drugs in the FDA pipeline as well as financing issues. View Details
Keywords: Decision Choices and Conditions; Financing and Loans; Health Care and Treatment; Health Disorders; Medical Specialties; Expansion; Health Industry; Atlanta
Herzlinger, Regina E., and Alfred Martin. "The Multiple Sclerosis Center of Atlanta." Harvard Business School Case 308-085, March 2008.
Amitabh Chandra
Amitabh Chandra is the Henry and Allison McCance Family Professor of Business Administration at Harvard Business School where he is the Faculty Chair of the joint
- 29 Oct 2021
- Blog Post
Helping Women in Mexico to Live Fulfilled and Healthy Lives
an online to offline customer journey, lowering the cost of health care for women. Plenna focuses on gynecology for modern women, aged 18 to 30 years old. First we want to... View Details
- 01 Jun 2007
- News
Profiles from the class of 2007
quality and outcomes. Consumers need to have that information to make good decisions.” Jain believes that any health-care system should center on a strong doctor-patient relationship and allow physicians sufficient time and opportunity to... View Details
Keywords: Garry Emmons;Julia Hanna;Lewis I. Rice
- May 11, 2017
- Article
Good Riddance to Big Insurance Mergers
By: Leemore S. Dafny
Federal judges issued preliminary injunctions halting mergers of four of the five largest U.S. health insurers. These decisions provide more precedent to support challenges of mergers between competitors in health care markets—whether payers or providers. View Details
Keywords: Mergers and Acquisitions; Insurance; Health Care and Treatment; Health Industry; Health Industry
Dafny, Leemore S. "Good Riddance to Big Insurance Mergers." New England Journal of Medicine 376, no. 19 (May 11, 2017): 1804–1806.
- 29 Sep 2014
- News
The Rise of the MD/MBA
- Article
Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures.
By: Ariel Dora Stern
The use of biomarkers holds great promise for the development of new therapeutics and the acceleration of clinical research. However, biomarkers must be validated—a complex and costly endeavor. Importantly, biomarker validation is meaningfully shaped by economic and... View Details
Stern, Ariel Dora. "Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures." Journal of Law, Medicine & Ethics 47, no. 3 (September 2019): 396–397.
- Article
Costs Without Value When Treating Pediatric Behavioral Patients in the ED
By: Marcella Jewell, Syed S. Shehab, Robert S. Kaplan, Jack Fanton and Joeli Hettler
Pediatric Emergency Department (ED) visits have greatly increased in recent years. An academic pediatric ED that annually treats about 1,000 behavioral health patients conducted a study to assess the true cost of caring for nonacute behavioral health patients. It... View Details
Jewell, Marcella, Syed S. Shehab, Robert S. Kaplan, Jack Fanton, and Joeli Hettler. "Costs Without Value When Treating Pediatric Behavioral Patients in the ED." NEJM Catalyst Innovations in Care Delivery 3, no. 2 (February 2022).
- 16 Dec 2014
- News
The Future of Green China
- Web
The MBA Class of 2022 Looks Back - MBA
Business & Environment Career Change Career and Professional Development Case Method Clubs Curriculum Digital Entrepreneurship FIELD Financial Aid Health Care Instagram Takeover JD/MBA Leadership Letters to... View Details
- 01 Dec 1998
- News
Managing the Business of Life
pressures I felt didn't come from work," she notes. "The problem was that as a woman in France I was expected to do it all outside the office, as well - take care of the kids, cook, and entertain elegantly.... View Details
- 13 Apr 2009
- Research & Ideas
Kind of Blue: Pushing Boundaries with Miles Davis
Ask jazz fans the world over to name their favorite compilation, and chances are their response is Kind of Blue. With music that is sophisticated and sublime, spare yet complex, trumpeter and composer Miles Davis (1926-1991) reached... View Details
Celia Stafford
Celia Stafford is a doctoral student in Health Policy (Management). She received a B.A. in Mathematics and Economics from Emory University in 2017 and an MPH focused in Biostatistics from the University of North Carolina at Chapel Hill in 2020. She is also... View Details
- November 2020
- Teaching Note
DayTwo: Going to Market with Gut Microbiome
By: Ayelet Israeli
Teaching Note for HBS Case No. 519-010. DayTwo is a young Israeli startup that applies research on the gut microbiome and machine learning algorithms to deliver personalized nutritional recommendations to its users in order to minimize blood sugar spikes after meals.... View Details
Keywords: Start-up Growth; Startup; Positioning; Targeting; Go To Market Strategy; B2B Vs. B2C; B2B2C; Health ＆ Wellness; AI; Machine Learning; Female Ceo; Female Protagonist; Science-based; Science And Technology Studies; Ecommerce; Applications; DTC; Direct To Consumer Marketing; US Health Care; ＂USA,＂; Innovation; Pricing; Business Growth; Segmentation; Distribution Channels; Growth and Development Strategy; Business Startups; Science-Based Business; Health; Innovation and Invention; Marketing; Information Technology; Business Growth and Maturation; E-commerce; Applications and Software; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; Israel; United States